DMDO-OH CAS 91526-18-0 Purity >97.0% (HPLC) Azilsartan Intermediate Factory

Short Description:

Name: 4-(Hydroxymethyl)-5-Methyl-1,3-Dioxol-2-One

Synonyms: DMDO-OH

CAS: 91526-18-0

Purity: >97.0% (HPLC)

Appearance: Colorless to Brownish-Yellow Liquid

Intermediate of Azilsartan (CAS: 147403-03-0)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4-(Hydroxymethyl)-5-Methyl-1,3-Dioxol-2-One (DMDO-OH) (CAS: 91526-18-0) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Chemical Name	4-(Hydroxymethyl)-5-Methyl-1,3-Dioxol-2-One
Synonyms	DMDO-OH; 4-(Hidroximetil)-5-Metil-1,3-Dioxol-2-One
CAS Number	91526-18-0
CAT Number	RF-PI1870
Stock Status	In Stock, Production Capacity 300 Tons/Year
Molecular Formula	C5H6O4
Molecular Weight	130.10
Boiling Point	108℃/0.5 mmHg
Specific Gravity (20/20℃)	1.32
Refractive Index	1.47
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Colorless to Brownish-Yellow Liquid
Identification Methods	HNMR, HPLC
Purity / Analysis Method	>97.0% (HPLC)
Water	<0.50%
Maximum Single Impurity	<2.00%
Total Impurities	<3.0%
Test Standard	Enterprise Standard
Shelf Life	1 Year
Usage	Intermediate of Azilsartan (CAS: 147403-03-0)

Package & Storage:

Package: Fluorinated Bottle, 25kg/Drum, or according to customer's requirement

Storage Condition: Store below 10℃ in a well-closed container; Protect from light and moisture

Advantages:

FAQ:

Application:

4-(Hydroxymethyl)-5-Methyl-1,3-Dioxol-2-One (CAS: 91526-18-0) is an intermediate of Azilsartan (CAS: 147403-03-0), Azilsartan Medoxomil (CAS: 863031-21-4). Azilsartan lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone. It is in the treatment of hypertension in the research and development of angiotensin II receptor antagonist drugs, used in the treatment of hypertension, is currently the only at the end of the clinical angiotensin II receptor antagonist drugs statins (sand). Azilsartan is an angiotensin II receptor blocker (ARB).